{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:31:47Z","timestamp":1764502307541,"version":"3.46.0"},"reference-count":38,"publisher":"Practical Medicine Publishing House","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Oncohematology"],"abstract":"<jats:p>Background &amp; Aims.\u00a0Hemorrhagic microthrombovasculitis (HMTV) is the most common disease among hypersensitive immunocomplex systemic vasculites. The high prevalence of the disease and increasing growth of the number of HMTV patients, the severity of the clinical course, and frequent joint, GIT, and kidney involvement (30\u201350\u00a0%) demonstrate the important social and economic significance of this problem and the need in further specification and evaluation of unspecified pathogenetic factors with development of new treatment approaches. The aim of this work is to evaluate the ristomycin-induced platelet aggregation, cytokines and homocysteine levels in HMTV patients.\r\nMethods.\u00a048 HMTV patients treated in the Kyrgyz Scientific Center for Hematology over the period from September, 2013, till March, 2015, were enrolled in the study (25 men and 23 women). The age median was 23 years. In all patients, the disease was diagnosed based on clinical data and lab test findings. The following lab tests were performed: ristomycin-induced platelet aggregation, cytokines and homocysteine levels in HMTV patients. The basic treatment options included the use of anticoagulants, antiaggregants, fibrinolysis activators, and prostacyclin; in case of II\u2013III activity degree of the autoimmune\/immunocomplex process, medium doses corticosteroids with anticoagulants, antiaggregants, and therapeutic plasmapheresis are used.\r\nResults.\u00a0The study demonstrated that patients with a high degree of activity of the autoimmune inflammation presented increased ristomycin-induced platelet aggregation, increased concentrations of interleukin-6 (IL-6) and tumor necrosis factor-a (TNF-a) and hyperhomocysteinemia. After the treatment, in patients with generalized HMTV, the concentrations of IL-6 and TNF-a reduced by 10\u00a0% and 18.3\u00a0%, respectively, but the IL-6 level remained above the normal limits.\r\nConclusion.\u00a0The data presented here demonstrate the importance of testing platelet aggregation upon the effect of specific inducers, as well as concentrations of proinflammatory cytokines and homocysteine in HMTV patients.<\/jats:p>","DOI":"10.21320\/2500-2139-2016-9-1-70-74","type":"journal-article","created":{"date-parts":[[2016,5,21]],"date-time":"2016-05-21T20:09:49Z","timestamp":1463861389000},"page":"70-74","source":"Crossref","is-referenced-by-count":1,"title":["Hemorrhagic Microthrombovasculitis: Primary Hemostasis and Immunological Parameters","\u0413\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u043c\u0438\u043a\u0440\u043e\u0442\u0440\u043e\u043c\u0431\u043e\u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442: \u043f\u0435\u0440\u0432\u0438\u0447\u043d\u044b\u0439 \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437 \u0438 \u0438\u043c\u043c\u0443\u043d\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0438"],"prefix":"10.21320","volume":"9","author":[{"given":"Abdukhalim Raimzhanovich","family":"Raimzhanov","sequence":"first","affiliation":[{"name":"Kyrgyz Scientific Center for Hematology, 4 Shakirov str., Bishkek, Kyrgyz Republic, 720055"},{"name":"\u041a\u044b\u0440\u0433\u044b\u0437\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u041c\u0417 \u041a\u0420, \u0443\u043b. \u0428\u0430\u043a\u0438\u0440\u043e\u0432\u0430, \u0434. 4, \u0411\u0438\u0448\u043a\u0435\u043a, \u041a\u044b\u0440\u0433\u044b\u0437\u0441\u043a\u0430\u044f \u0420\u0435\u0441\u043f\u0443\u0431\u043b\u0438\u043a\u0430, 720055"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. A.","family":"Dzhakypbaev","sequence":"additional","affiliation":[{"name":"Kyrgyz Scientific Center for Hematology, 4 Shakirov str., Bishkek, Kyrgyz Republic, 720055"},{"name":"\u041a\u044b\u0440\u0433\u044b\u0437\u0441\u043a\u0438\u0439 \u043d\u0430\u0443\u0447\u043d\u044b\u0439 \u0446\u0435\u043d\u0442\u0440 \u0433\u0435\u043c\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438 \u041c\u0417 \u041a\u0420, \u0443\u043b. \u0428\u0430\u043a\u0438\u0440\u043e\u0432\u0430, \u0434. 4, \u0411\u0438\u0448\u043a\u0435\u043a, \u041a\u044b\u0440\u0433\u044b\u0437\u0441\u043a\u0430\u044f \u0420\u0435\u0441\u043f\u0443\u0431\u043b\u0438\u043a\u0430, 720055"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"8834","published-online":{"date-parts":[[2016,1,1]]},"reference":[{"key":"16558","unstructured":"\u0411\u0430\u0440\u043a\u0430\u0433\u0430\u043d \u0417.\u0421. \u0413\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f \u0438 \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u044b. \u041c.: \u041c\u0435\u0434\u0438\u0446\u0438\u043d\u0430, 1988. 463 \u0441."},{"key":"16559","unstructured":"[Barkagan ZS. Gemorragicheskie zabolevaniya i sindromy. (Hemorrhagic diseases and syndromes.) Moscow: Meditsina Publ.; 1988. 463 p. (In Russ)]"},{"key":"16560","unstructured":"\u0411\u0430\u0440\u043a\u0430\u0433\u0430\u043d \u0417.\u0421., \u041c\u043e\u043c\u043e\u0442 \u0410.\u041f. \u041e\u0441\u043d\u043e\u0432\u044b \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0438 \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0439 \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437\u0430. \u041c.: \u041d\u044c\u044e\u0434\u0438\u0430\u043c\u0435\u0434, 1999. 216 \u0441."},{"key":"16561","unstructured":"[Barkagan ZS, Momot AP. Osnovy diagnostiki narushenii gemostaza. (Fundamentals of diagnosis of hemostatic disorders.) Moscow: Newdiamed Publ.; 1999. 216 p. (In Russ)]"},{"key":"16562","unstructured":"\u0414\u0436\u0430\u043a\u044b\u043f\u0431\u0430\u0435\u0432 \u041e.\u0410. \u041a\u043b\u0438\u043d\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u043a\u0430\u0440\u0442\u0438\u043d\u0430, \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0438 \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437\u0430 \u0438 \u0438\u043c\u043c\u0443\u043d\u043d\u043e\u0439 \u0441\u0438\u0441\u0442\u0435\u043c\u044b \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0433\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u043c \u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442\u043e\u043c \u0432 \u043f\u0440\u043e\u0446\u0435\u0441\u0441\u0435 \u043a\u043e\u043c\u0431\u0438\u043d\u0438\u0440\u043e\u0432\u0430\u043d\u043d\u043e\u0433\u043e \u043b\u0435\u0447\u0435\u043d\u0438\u044f \u043d\u0438\u0437\u043a\u043e\u043c\u043e\u043b\u0435\u043a\u0443\u043b\u044f\u0440\u043d\u044b\u043c \u0433\u0435\u043f\u0430\u0440\u0438\u043d\u043e\u043c \u0438 \u0441\u0435\u0430\u043d\u0441\u0430\u043c\u0438 \u043b\u0435\u0447\u0435\u0431\u043d\u043e\u0433\u043e \u043f\u043b\u0430\u0437\u043c\u0430\u0444\u0435\u0440\u0435\u0437\u0430: \u0410\u0432\u0442\u043e\u0440\u0435\u0444. \u0434\u0438\u0441. \u00bc \u043a\u0430\u043d\u0434. \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. \u0411\u0438\u0448\u043a\u0435\u043a, 2002. 22 \u0441."},{"key":"16563","unstructured":"[Dzhakypbaev OA. Klinicheskaya kartina, pokazateli gemostaza i immunnoi sistemy u bol\u2019nykh gemorragicheskim vaskulitom v protsesse kombinirovannogo lecheniya nizkomolekulyarnym geparinom i seansami lechebnogo plazmafereza. (Clinical presentation, parameters of hemostasis and immune system in patients with hemorrhagic vasculitis during combined treatment with low molecular weight heparin and therapeutic plasmapheresis.) [dissertation] Bishkek; 2002. 22 p. (In Russ)]"},{"key":"16564","unstructured":"\u041b\u0430\u043f\u0438\u043d \u0421.\u0412., \u0422\u043e\u0442\u043e\u043b\u044f\u043d \u0410.\u0410. \u0418\u043c\u043c\u0443\u043d\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0434\u0438\u0430\u0433\u043d\u043e\u0441\u0442\u0438\u043a\u0430 \u043f\u043e\u0440\u0430\u0436\u0435\u043d\u0438\u0439 \u043f\u043e\u0447\u0435\u043a \u043f\u0440\u0438 \u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442\u0430\u0445. \u041d\u0435\u0444\u0440\u043e\u043b\u043e\u0433\u0438\u044f. 2003;1:109\u201319."},{"key":"16565","unstructured":"[Lapin SV, Totolyan AA. Immunologic diagnosis of kidney impairment in vasculitis. Nefrologiya. 2003;1:109\u201319. (In Russ)]"},{"key":"16566","unstructured":"\u0420\u0430\u0438\u043c\u0436\u0430\u043d\u043e\u0432 \u0410.\u0420., \u0414\u0436\u0430\u043a\u044b\u043f\u0431\u0430\u0435\u0432 \u041e.\u0410. \u0413\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0439 \u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442 \u0438 \u0441\u043e\u0432\u0440\u0435\u043c\u0435\u043d\u043d\u0430\u044f \u0430\u043d\u0442\u0438\u0442\u0440\u043e\u043c\u0431\u043e\u0442\u0438\u0447\u0435\u0441\u043a\u0430\u044f \u0442\u0435\u0440\u0430\u043f\u0438\u044f. \u0411\u0438\u0448\u043a\u0435\u043a, 2008. 144 \u0441."},{"key":"16567","unstructured":"[Raimzhanov AR, Dzhakypbaev OA. Gemorragicheskii vaskulit i sovremennaya antitromboticheskaya terapiya. (Hemorrhagic vasculitis and modern anti-thrombotic therapy.) Bishkek; 2008. 144 p. (In Russ)]"},{"key":"16568","unstructured":"\u0414\u0436\u0430\u043a\u044b\u043f\u0431\u0430\u0435\u0432 \u041e.\u0410., \u0426\u043e\u043f\u043e\u0432\u0430 \u0418.\u0410. \u0418\u0437\u0443\u0447\u0435\u043d\u0438\u0435 \u0430\u0433\u0440\u0435\u0433\u0430\u0446\u0438\u0438 \u0442\u0440\u043e\u043c\u0431\u043e\u0446\u0438\u0442\u043e\u0432 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0433\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u043c \u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442\u043e\u043c. \u0426\u0435\u043d\u0442\u0440\u0430\u043b\u044c\u043d\u043e-\u0410\u0437\u0438\u0430\u0442\u0441\u043a\u0438\u0439 \u043c\u0435\u0434\u0438\u0446\u0438\u043d\u0441\u043a\u0438\u0439 \u0436\u0443\u0440\u043d\u0430\u043b. 2010; XVI(4):24\u20136."},{"key":"16569","unstructured":"[Dzhakypbaev OA, Tsopova IA. Examination of platelet aggregation in patients with hemorrhagic vasculitis. Tsentral\u2019no-Aziatskii meditsinskii zhurnal. 2010; XVI(4):24\u20136. (In Russ)]"},{"key":"16570","unstructured":"\u0415\u043c\u0430\u043d\u0443\u0439\u043b\u043e\u0432\u0430 \u041d.\u0412. \u0413\u0435\u043c\u043e\u0440\u0435\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0438 \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0438 \u043f\u0440\u0438 \u0441\u0438\u0441\u0442\u0435\u043c\u043d\u043e\u0439 \u043a\u0440\u0430\u0441\u043d\u043e\u0439 \u0432\u043e\u043b\u0447\u0430\u043d\u043a\u0435, \u043d\u0435\u043a\u043e\u0442\u043e\u0440\u044b\u0445 \u0444\u043e\u0440\u043c\u0430\u0445 \u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442\u043e\u0432 \u0438 \u043d\u0435\u0440\u0435\u0432\u043c\u0430\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0445 \u0432\u0430\u0441\u043a\u0443\u043b\u043e\u043f\u0430\u0442\u0438\u044f\u0445: \u0410\u0432\u0442\u043e\u0440\u0435\u0444. \u0434\u0438\u0441. \u00bc \u043a\u0430\u043d\u0434. \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. \u042f\u0440\u043e\u0441\u043b\u0430\u0432\u043b\u044c, 2011. 20 \u0441."},{"key":"16571","unstructured":"[Emanuilova NV. Gemoreologicheskie i gemostaziologicheskie pokazateli pri sistemnoi krasnoi volchanke, nekotorykh formakh vaskulitov i nerevmaticheskikh vaskulopatiyakh. (Hemorheological and hemostatic parameters in systemic lupus erythematosus and non-rheumatic vasulopathies.) [dissertation] Yaroslavl\u2019; 2011. 20 p. (In Russ)]"},{"key":"16572","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1514-0"},{"key":"16573","doi-asserted-by":"publisher","DOI":"10.1007\/s00467-004-1673-z"},{"key":"16574","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-07-2842"},{"key":"16575","doi-asserted-by":"publisher","DOI":"10.1016\/j.semnephrol.2007.02.004"},{"key":"16576","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-004-0068-2"},{"key":"16577","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2006.07.023"},{"key":"16578","unstructured":"Topaloglu R, Sungur A, Baskin E, et al. Vascular endothelial growth factor in Henoch\u2013Schonlein purpura. J Rheumatol. 2001;28(10):2269\u201373."},{"key":"16579","unstructured":"\u041d\u0430\u0441\u043e\u043d\u043e\u0432 \u0415.\u041b., \u0428\u0438\u043b\u043a\u0438\u043d\u0430 \u041d.\u041f., \u0411\u0430\u0440\u0430\u043d\u043e\u0432 \u0410.\u0410. \u0412\u0430\u0441\u043a\u0443\u043b\u0438\u0442\u044b \u0438 \u0432\u0430\u0441\u043a\u0443\u043b\u043e\u043f\u0430\u0442\u0438\u0438. \u042f\u0440\u043e\u0441\u043b\u0430\u0432\u043b\u044c: \u0412\u0435\u0440\u0445\u043d\u044f\u044f \u0412\u043e\u043b\u0433\u0430, 1999. 616 \u0441."},{"key":"16580","unstructured":"[Nasonov EL, Shilkina NP, Baranov AA. Vaskulity i vaskulopatii. (Vasculites and vasculopathies.) Yaroslavl\u2019: Verkhnyaya Volga Publ.; 1999. 616 p. (In Russ)]"},{"key":"16581","unstructured":"\u0415\u043c\u0430\u043d\u0443\u0439\u043b\u043e\u0432 \u0412.\u0418. \u0424\u0430\u043a\u0442\u043e\u0440 \u043d\u0435\u043a\u0440\u043e\u0437\u0430 \u043e\u043f\u0443\u0445\u043e\u043b\u0438 a, \u0438\u043d\u0442\u0435\u0440\u043b\u0435\u0439\u043a\u0438\u043d-4, \u0421-\u0440\u0435\u0430\u043a\u0442\u0438\u0432\u043d\u044b\u0439 \u0431\u0435\u043b\u043e\u043a \u0438 \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437\u0438\u043e\u043b\u043e\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043f\u043e\u043a\u0430\u0437\u0430\u0442\u0435\u043b\u0438 \u0443 \u0431\u043e\u043b\u044c\u043d\u044b\u0445 \u0441\u0438\u0441\u0442\u0435\u043c\u043d\u043e\u0439 \u043a\u0440\u0430\u0441\u043d\u043e\u0439 \u0432\u043e\u043b\u0447\u0430\u043d\u043a\u043e\u0439 \u0438 \u0433\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u043c \u0432\u0430\u0441\u043a\u0443\u043b\u0438\u0442\u043e\u043c: \u0410\u0432\u0442\u043e\u0440\u0435\u0444. \u0434\u0438\u0441. \u00bc \u043a\u0430\u043d\u0434. \u043c\u0435\u0434. \u043d\u0430\u0443\u043a. \u042f\u0440\u043e\u0441\u043b\u0430\u0432\u043b\u044c, 2007. 19 \u0441."},{"key":"16582","unstructured":"[Emanuilov VI. Faktor nekroza opukholi a, interleikin-4, S-reaktivnyi belok i gemostaziologicheskie pokazateli u bol\u2019nykh sistemnoi krasnoi volchankoi i gemorragicheskim vaskulitom. (Tumor necrosis factor alfa, interleukin-4, C-reactive protein and hemostatic parameters in patients with systemic lupus erythematosus and hemorrhagic vasculitis.) [dissertation] Yaroslavl\u2019; 2007. 19 p. (In Russ)]"},{"key":"16583","doi-asserted-by":"publisher","DOI":"10.1160\/TH07-01-0039"},{"key":"16584","unstructured":"\u0411\u0430\u0440\u043a\u0430\u0433\u0430\u043d \u0417.\u0421., \u041a\u043e\u0441\u0442\u044e\u0447\u0435\u043d\u043a\u043e \u0413.\u0418., \u041a\u043e\u0442\u043e\u0432\u0449\u0438\u043a\u043e\u0432\u0430 \u0415.\u0424. \u0413\u0438\u043f\u0435\u0440\u0433\u043e\u043c\u043e\u0446\u0438\u0441\u0442\u0435\u0438\u043d\u0435\u043c\u0438\u044f \u043a\u0430\u043a \u0441\u0430\u043c\u043e\u0441\u0442\u043e\u044f\u0442\u0435\u043b\u044c\u043d\u044b\u0439 \u0444\u0430\u043a\u0442\u043e\u0440 \u0440\u0438\u0441\u043a\u0430 \u043f\u043e\u0440\u0430\u0436\u0435\u043d\u0438\u044f \u0438 \u0442\u0440\u043e\u043c\u0431\u043e\u0437\u0430 \u043a\u0440\u043e\u0432\u0435\u043d\u043e\u0441\u043d\u044b\u0445 \u0441\u043e\u0441\u0443\u0434\u043e\u0432. \u041f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u044f \u043a\u0440\u043e\u0432\u043e\u043e\u0431\u0440\u0430\u0449\u0435\u043d\u0438\u044f \u0438 \u043a\u0430\u0440\u0434\u0438\u043e\u0445\u0438\u0440\u0443\u0440\u0433\u0438\u044f. 2002;1:65\u201371."},{"key":"16585","unstructured":"[Barkagan ZS, Kostyuchenko GI, Kotovshchikova EF. Hyperhomocystenemia as an independent risk factor of injury and thrombosis of blood vessels. Patologiya krovoobrashcheniya i kardiokhirurgiya. 2002;1:65\u201371. (In Russ)]"},{"key":"16586","unstructured":"\u0422\u0430\u0434\u0442\u0430\u0435\u0432\u0430 \u0417.\u0421., \u041a\u0430\u0446\u0430\u0434\u0437\u0435 \u042e.\u041b. \u0413\u0435\u043d\u0435\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u043f\u0440\u0438\u0437\u043d\u0430\u043a\u0438 \u0442\u0440\u043e\u043c\u0431\u043e\u0444\u0438\u043b\u0438\u0438 \u0438 \u0443\u0440\u043e\u0432\u0435\u043d\u044c \u0433\u043e\u043c\u043e\u0446\u0438\u0441\u0442\u0435\u0438\u043d\u0430 \u0432 \u043a\u0440\u043e\u0432\u0438 \u043f\u0440\u0438 \u043c\u0438\u0433\u0440\u0435\u043d\u0438 \u0438 \u043e\u0441\u0442\u0440\u043e\u043c \u043d\u0430\u0440\u0443\u0448\u0435\u043d\u0438\u0438 \u043c\u043e\u0437\u0433\u043e\u0432\u043e\u0433\u043e \u043a\u0440\u043e\u0432\u043e\u043e\u0431\u0440\u0430\u0449\u0435\u043d\u0438\u044f \u0443 \u0434\u0435\u0442\u0435\u0439. \u0422\u0440\u043e\u043c\u0431\u043e\u0437, \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437 \u0438 \u0440\u0435\u043e\u043b\u043e\u0433\u0438\u044f. 2004;4(20):38\u201344."},{"key":"16587","unstructured":"[Tadtaeva ZS, Katsadze YuL. Genetic signs of thrombophilia and homocystein blood level in migraine and acute cerebrovascular episode in children. Tromboz, gemostaz i reologiya. 2004;4(20):38\u201344. (In Russ)]"},{"key":"16588","unstructured":"\u041a\u0443\u0437\u043d\u0438\u043a \u0411.\u0418., \u0421\u0442\u0443\u0440\u043e\u0432 \u0412.\u0413., \u041c\u0430\u043a\u0441\u0438\u043c\u043e\u0432\u0430 \u041e.\u0413. \u0413\u0435\u043c\u043e\u0440\u0440\u0430\u0433\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0438 \u0442\u0440\u043e\u043c\u0431\u043e\u0442\u0438\u0447\u0435\u0441\u043a\u0438\u0435 \u0437\u0430\u0431\u043e\u043b\u0435\u0432\u0430\u043d\u0438\u044f \u0438 \u0441\u0438\u043d\u0434\u0440\u043e\u043c\u044b \u0443 \u0434\u0435\u0442\u0435\u0439. \u041d\u043e\u0432\u043e\u0441\u0438\u0431\u0438\u0440\u0441\u043a: \u041d\u0430\u0443\u043a\u0430, 2012. 456 \u0441."},{"key":"16589","unstructured":"[Kuznik BI, Sturov VG, Maksimova OG. Gemorragicheskie i tromboticheskie zabolevaniya i sindromy u detei. (Hemorrhagic and thrombotic diseases and syndromes in children.) Novosibirsk: Nauka Publ.; 2012. 456 p. (In Russ)]"},{"key":"16590","unstructured":"\u041a\u0443\u0437\u043d\u0438\u043a \u0411.\u0418. \u041a\u043b\u0435\u0442\u043e\u0447\u043d\u044b\u0435 \u0438 \u043c\u043e\u043b\u0435\u043a\u0443\u043b\u044f\u0440\u043d\u044b\u0435 \u043c\u0435\u0445\u0430\u043d\u0438\u0437\u043c\u044b \u0440\u0435\u0433\u0443\u043b\u044f\u0446\u0438\u0438 \u0441\u0438\u0441\u0442\u0435\u043c\u044b \u0433\u0435\u043c\u043e\u0441\u0442\u0430\u0437\u0430 \u0432 \u043d\u043e\u0440\u043c\u0435 \u0438 \u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438. \u0427\u0438\u0442\u0430: \u042d\u043a\u0441\u043f\u0440\u0435\u0441\u0441-\u0438\u0437\u0434\u0430\u0442\u0435\u043b\u044c\u0441\u0442\u0432\u043e, 2010. 828 \u0441."},{"key":"16591","unstructured":"[Kuznik BI. Kletochnye i molekulyarnye mekhanizmy regulyatsii sistemy gemostaza v norme i patologii. (Cellular and molecular mechanisms of hemostasis system regulation under normal and pathological conditions.) Chita: Ekspress-izdatel\u2019stvo Publ.; 2010. 828 p. (In Russ)]"},{"key":"16592","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V81.11.2827.bloodjournal81112827"},{"key":"16593","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/72.2.315"},{"key":"16594","doi-asserted-by":"publisher","DOI":"10.1160\/TH11-09-0677"},{"key":"16595","doi-asserted-by":"publisher","DOI":"10.7205\/MILMED.169.4.325"}],"container-title":["Clinical Oncohematology"],"original-title":[],"link":[{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/471\/435","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/download\/471\/435","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,30]],"date-time":"2025-11-30T11:28:21Z","timestamp":1764502101000},"score":1,"resource":{"primary":{"URL":"https:\/\/bloodjournal.ru\/index.php\/coh\/article\/view\/471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,1,1]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2016,1,1]]}},"URL":"https:\/\/doi.org\/10.21320\/2500-2139-2016-9-1-70-74","relation":{},"ISSN":["2500-2139","1997-6933"],"issn-type":[{"type":"electronic","value":"2500-2139"},{"type":"print","value":"1997-6933"}],"subject":[],"published":{"date-parts":[[2016,1,1]]}}}